A detailed history of Bvf Inc transactions in Elevation Oncology, Inc. stock. As of the latest transaction made, Bvf Inc holds 2,966,836 shares of ELEV stock, worth $1.69 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
2,966,836
Previous 2,312,200 28.31%
Holding current value
$1.69 Million
Previous $6.24 Million 71.48%
% of portfolio
0.06%
Previous 0.19%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$0.56 - $3.02 $366,596 - $1.98 Million
654,636 Added 28.31%
2,966,836 $1.78 Million
Q2 2022

Aug 15, 2022

BUY
$1.26 - $3.94 $2 - $7
2 Added 0.0%
2,312,200 $3.24 Million
Q1 2022

May 16, 2022

BUY
$2.34 - $6.41 $1.64 Million - $4.49 Million
700,500 Added 43.46%
2,312,198 $5.83 Million
Q4 2021

Feb 14, 2022

BUY
$4.15 - $8.86 $88,810 - $189,604
21,400 Added 1.35%
1,611,698 $9.7 Million
Q3 2021

Nov 15, 2021

BUY
$7.66 - $16.11 $53 - $112
7 Added 0.0%
1,590,298 $12.4 Million
Q2 2021

Aug 16, 2021

BUY
$11.44 - $13.57 $18.2 Million - $21.6 Million
1,590,291 New
1,590,291 $21.6 Million

Others Institutions Holding ELEV

About Elevation Oncology, Inc.


  • Ticker ELEV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 23,300,900
  • Market Cap $13.3M
  • Description
  • Elevation Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of cancer in genomically defined patient populations in the United States. The company's lead program is the seribantumab, an anti-HER3 monoclonal antibody that is in Phase II CRESTONE trial for the treatment of advanced sol...
More about ELEV
Track This Portfolio

Track Bvf Inc Portfolio

Follow Bvf Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bvf Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bvf Inc with notifications on news.